KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Long-Term Investments (2020 - 2026)

AbCellera Biologics filings provide 7 years of Long-Term Investments readings, the most recent being $65.3 million for Q1 2026.

  • Quarterly Long-Term Investments fell 19.93% to $65.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $65.3 million through Mar 2026, down 19.93% year-over-year, with the annual reading at $62.6 million for FY2025, 23.96% down from the prior year.
  • Long-Term Investments hit $65.3 million in Q1 2026 for AbCellera Biologics, up from $62.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $93.3 million in Q3 2025 and bottomed at $57.6 million in Q1 2023.
  • Average Long-Term Investments over 5 years is $71.5 million, with a median of $66.7 million recorded in 2022.
  • The largest annual shift saw Long-Term Investments surged 82.94% in 2022 before it decreased 23.96% in 2025.
  • AbCellera Biologics' Long-Term Investments stood at $72.5 million in 2022, then decreased by 9.08% to $65.9 million in 2023, then increased by 24.81% to $82.3 million in 2024, then dropped by 23.96% to $62.6 million in 2025, then increased by 4.36% to $65.3 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Long-Term Investments are $65.3 million (Q1 2026), $62.6 million (Q4 2025), and $93.3 million (Q3 2025).